Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

365
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
365
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

67
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
67
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

84
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
84
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

249
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
249
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

92
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
92
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

129
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
129

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Pharmacist Board Certification on Health Outcomes of Critically Ill Patients: An Analysis of the Optimizing Pharmacist-Team Integration for ICU Patient Management (OPTIM) Study.

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

A Survey of Hospital Pharmacy Leader Perspectives on Advocating for Clinical Pharmacy Services.

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

Optimizing Pharmacist Team-Integration for ICU Patient Management (OPTIM): Recruitment and Retention Strategies to Mobilize a Professional Community.

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

Pharmacotherapeutic Controversies During Temperature Control After Out-of-Hospital Cardiac Arrest: A Semi-Structured Literature Review.

Pharmacotherapy·2026
Same author

Consensus recommendations for the integration of critical care pharmacists on intensive care unit teams: Endorsed by the American Association of Critical-Care Nurses, American College of Clinical Pharmacy, American Society of Health-System Pharmacists, Institute for Safe Medication Practices, and Society of Critical Care Medicine.

Journal of the American College of Clinical Pharmacy : JACCP·2025
Same author

Exploring the Link Between Intravenous Methocarbamol and Acute Kidney Injury.

Journal of pharmacy practice·2025

Related Experiment Video

Updated: Nov 21, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.2K

Optimizing ceftaroline dosing in critically ill patients undergoing continuous renal replacement therapy.

Shamir Kalaria1,2, Sarah Williford2, Dong Guo3

  • 1Center for Translational Medicine, School of Pharmacy, University of Maryland, Baltimore, Maryland, USA.

Pharmacotherapy
|January 13, 2021
PubMed
Summary

This study provides dosing recommendations for ceftaroline fosamil in critically ill patients on continuous renal replacement therapy (CRRT). Ceftaroline is cleared extensively during CRRT, necessitating dose adjustments based on therapy intensity and patient weight.

Keywords:
ceftarolinecontinuous renal replacement therapycritical carepharmacokinetics

More Related Videos

Isolation, Characterization, And High Throughput Extracellular Flux Analysis of Mouse Primary Renal Tubular Epithelial Cells
09:40

Isolation, Characterization, And High Throughput Extracellular Flux Analysis of Mouse Primary Renal Tubular Epithelial Cells

Published on: June 20, 2018

18.2K
Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development
09:43

Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development

Published on: August 10, 2015

16.3K

Related Experiment Videos

Last Updated: Nov 21, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.2K
Isolation, Characterization, And High Throughput Extracellular Flux Analysis of Mouse Primary Renal Tubular Epithelial Cells
09:40

Isolation, Characterization, And High Throughput Extracellular Flux Analysis of Mouse Primary Renal Tubular Epithelial Cells

Published on: June 20, 2018

18.2K
Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development
09:43

Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development

Published on: August 10, 2015

16.3K

Area of Science:

  • Pharmacokinetics and pharmacodynamics
  • Critical care medicine
  • Nephrology

Background:

  • Ceftaroline fosamil dosing is not established for patients on continuous renal replacement therapy (CRRT).
  • Critically ill patients on CRRT require specific pharmacokinetic assessments for antibiotic efficacy.

Purpose of the Study:

  • Characterize ceftaroline pharmacokinetics in critically ill patients undergoing CRRT.
  • Develop individualized ceftaroline fosamil dosing recommendations for CRRT patients.

Main Methods:

  • Pharmacokinetic study involving critically ill patients on various CRRT modalities.
  • Collected plasma and ultrafiltrate samples for ceftaroline concentration analysis.
  • Utilized non-compartmental analysis to determine pharmacokinetic parameters.

Main Results:

  • Ceftaroline demonstrated high filter efficiency (0.81 ± 0.1) during CRRT.
  • Non-renal clearance exceeded 50% of total clearance, indicating significant drug removal.
  • Proposed a dosing regimen of 400 mg every 12 hours for a 70 kg patient at 3 L/h effluent flow rate.

Conclusions:

  • Ceftaroline undergoes extensive clearance in CRRT patients, potentially affecting target achievement.
  • Dose adjustments are crucial and should consider CRRT intensity, patient weight, and clinical status.